Post Market Clinical Follow up of ResMed Mask Systems
← catalyst calendarNCT05262439 · readout ≤ 315 d
Sponsored by ResMed (industry) · RMD — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
500estimated
Sites
1
Country
Australia
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-05-26 | actual | When the study began enrolling |
| Primary completion | Jun 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2022-03-02 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-29 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Obstructive Sleep Apnea
Intervention
- Device: New generation CPAP mask
Primary outcomes
what the primary-completion date above is the date OFApnea Hypopnea Index (event/hour)
measured up to 90 days
Usage Hours (hours/night)
measured up to 90 days
Leak (L/minute)
measured up to 90 days
CPAP Pressure (cmH2O)
measured up to 90 days
Adverse Events
measured up to 90 days
Publications
- PMID 39498349 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · RMD's whole pipeline · Catalyst calendar · Every registered study · What changed